• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过影像学检查帕金森病来验证 Braak 假说。

Examining Braak's hypothesis by imaging Parkinson's disease.

机构信息

MRC Clinical Sciences Centre and Division of Neuroscience and Mental Health, Faculty of Medicine, Imperial College, Hammersmith Hospital, London, UK.

出版信息

Mov Disord. 2010;25 Suppl 1:S83-8. doi: 10.1002/mds.22720.

DOI:10.1002/mds.22720
PMID:20187242
Abstract

In this review, in vivo patterns of structural, metabolic, and neurotransmitter binding changes revealed by imaging in both symptomatic Parkinson's disease (PD) and at-risk subjects are compared with those predicted at different Braak stages. It is concluded that the dysfunction revealed by imaging in PD is only partially in line with the sequential ascending topography of Lewy body pathology reported by Braak, suggesting that neurons in different brain regions are likely to be selectively vulnerable to the presence of intracellular synuclein aggregates.

摘要

在这篇综述中,对比了在有症状的帕金森病 (PD) 患者和高危人群中通过成像观察到的结构、代谢和神经递质结合变化的体内模式与不同 Braak 阶段预测的模式。结论是,PD 中成像显示的功能障碍与 Braak 报告的路易体病理的顺序上升拓扑结构仅部分一致,这表明不同脑区的神经元可能容易受到细胞内突触核蛋白聚集物的影响。

相似文献

1
Examining Braak's hypothesis by imaging Parkinson's disease.通过影像学检查帕金森病来验证 Braak 假说。
Mov Disord. 2010;25 Suppl 1:S83-8. doi: 10.1002/mds.22720.
2
In vivo imaging neurotransmitter function. The rat 6-hydroxydopamine model and its relevance for human Parkinson's disease.体内成像神经递质功能。大鼠6-羟基多巴胺模型及其与人类帕金森病的相关性。
Nuklearmedizin. 2011;50(4):155-66. doi: 10.3413/Nukmed-0371-10-12. Epub 2011 Mar 16.
3
Does Parkinson's disease start in the gut?帕金森病始于肠道吗?
Acta Neuropathol. 2018 Jan;135(1):1-12. doi: 10.1007/s00401-017-1777-8. Epub 2017 Oct 16.
4
Exploring Braak's Hypothesis of Parkinson's Disease.探索布拉克帕金森病假说
Front Neurol. 2017 Feb 13;8:37. doi: 10.3389/fneur.2017.00037. eCollection 2017.
5
Evaluation of the Braak hypothesis: how far can it explain the pathogenesis of Parkinson's disease?评估 Braak 假说:它能在多大程度上解释帕金森病的发病机制?
Expert Rev Neurother. 2012 Jun;12(6):673-86. doi: 10.1586/ern.12.47.
6
Lewy body-related alpha-synucleinopathy in the aged human brain.老年人大脑中与路易体相关的α-突触核蛋白病。
J Neural Transm (Vienna). 2004 Oct;111(10-11):1219-35. doi: 10.1007/s00702-004-0138-7. Epub 2004 Apr 2.
7
New developments of brain imaging for Parkinson's disease and related disorders.帕金森病及相关疾病的脑成像新进展。
Mov Disord. 2006 Dec;21(12):2035-41. doi: 10.1002/mds.20845.
8
Recent developments in the neuropathological diagnosis of Parkinson's disease and parkinsonism.
Acta Neurol Belg. 2003 Sep;103(3):155-8.
9
Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.在帕金森病早期,α-突触核蛋白重新分布至黑质中的神经黑素脂质。
Brain. 2005 Nov;128(Pt 11):2654-64. doi: 10.1093/brain/awh584. Epub 2005 Jul 6.
10
Stage-dependent nigral neuronal loss in incidental Lewy body and Parkinson's disease.散发性路易体病和帕金森病中黑质神经元丢失的分期依赖性
Mov Disord. 2014 Sep;29(10):1244-51. doi: 10.1002/mds.25952. Epub 2014 Jul 3.

引用本文的文献

1
Targeting the Gut-Brain Axis with Fecal Microbiota Transplantation: Considerations on a Potential Novel Treatment for Parkinson's Disease.通过粪便微生物群移植靶向肠-脑轴:对帕金森病潜在新疗法的思考
Mov Disord Clin Pract. 2022 Dec 7;10(Suppl 2):S21-S25. doi: 10.1002/mdc3.13621. eCollection 2023 Aug.
2
Simulating the progression of brain structural alterations in Parkinson's disease.模拟帕金森病脑结构改变的进展
NPJ Parkinsons Dis. 2022 Jun 28;8(1):86. doi: 10.1038/s41531-022-00349-0.
3
Advanced brain ageing in Parkinson's disease is related to disease duration and individual impairment.
帕金森病中的脑高级老化与病程及个体损伤有关。
Brain Commun. 2021 Aug 23;3(3):fcab191. doi: 10.1093/braincomms/fcab191. eCollection 2021.
4
Alterations of Regional Homogeneity in the Mild and Moderate Stages of Parkinson's Disease.帕金森病轻度和中度阶段局部一致性的改变。
Front Aging Neurosci. 2021 Jul 21;13:676899. doi: 10.3389/fnagi.2021.676899. eCollection 2021.
5
Perspective: Treatment for Disease Modification in Chronic Neurodegeneration.观点:慢性神经退行性变疾病修饰治疗。
Cells. 2021 Apr 12;10(4):873. doi: 10.3390/cells10040873.
6
Shared cerebral metabolic pathology in non-transgenic animal models of Alzheimer's and Parkinson's disease.阿尔茨海默病和帕金森病非转基因动物模型中的共享脑代谢病理学。
J Neural Transm (Vienna). 2020 Feb;127(2):231-250. doi: 10.1007/s00702-020-02152-8. Epub 2020 Feb 6.
7
α-Synuclein in Parkinson's disease: causal or bystander?α-突触核蛋白在帕金森病中的作用:是病因还是旁观者?
J Neural Transm (Vienna). 2019 Jul;126(7):815-840. doi: 10.1007/s00702-019-02025-9. Epub 2019 Jun 25.
8
Spinal Lewy body pathology in older adults without an antemortem diagnosis of Parkinson's disease.老年人的脊髓路易体病变,这些老年人在生前没有帕金森病的诊断。
Brain Pathol. 2018 Jul;28(4):560-568. doi: 10.1111/bpa.12560. Epub 2017 Oct 27.
9
Catechol-O-methyltransferase inhibitors in Parkinson's disease.儿茶酚-O-甲基转移酶抑制剂在帕金森病中的应用。
Drugs. 2015 Feb;75(2):157-74. doi: 10.1007/s40265-014-0343-0.
10
Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with familial Parkinson's disease.人诱导多能干细胞衍生的家族性帕金森病患者神经元中线粒体缺陷的药物干预。
Sci Transl Med. 2012 Jul 4;4(141):141ra90. doi: 10.1126/scitranslmed.3003985.